Device, diagnostics and nutrition companies at ObesityWeek 2026
Nov 14–17, 2026 National Harbor, MD ~4.4k attendees Website
31 device, diagnostics and nutrition companies are at ObesityWeek 2026 — 18 presentations on the program and 22 with a booth in the exhibit hall. Most represented: Dexcom (3 on the program), Perspectum (3 on the program), Medifast (2 on the program). 26 of them have their own page in this guide. As of Nov 12, 2026.
Topic
Top represented
Showing 1–17 of 31 organizations
| Organization | ObesityWeek 2026 Attendance |
|---|---|
Dexcom San Diego, CA | |
Maker of continuous glucose monitoring systems that people use to manage diabetes and track their glucose. | Booth Exhibiting at Booth 709 Sat, Nov 147pm–9:30pmSun, Nov 159:30am–4pmMon, Nov 169:30am–4pm Poster Sat Nov 14 7:30pm–8:30pm 18-Month Weight Outcomes with Dexcom G7 CGM in Non-Insulin–Treated T2D: US Primary Care Registry Chronic disease and obesity complicationsObesity pharmacotherapy and drug development Poster Sat Nov 14 7:30pm–8:30pm BMI Differences in Psychosocial and Behavior Outcomes After CGM Use in Adults With Type 2 Diabetes Chronic disease and obesity complicationsMetabolism and integrative physiology Poster Sat Nov 14 7:30pm–8:30pm Combined Effect of RT-CGM and Tirzepatide on HbA1c and BMI Change in Type 2 Diabetes not on Insulin Metabolism and integrative physiology |
Perspectum Oxford, UK | |
MRI-based software for assessing liver and metabolic disease, used in clinical trials and care. | Talk Sat Nov 14 3:00pm–3:15pm Poster Sat Nov 14 7:30pm–8:30pm Repeatability and Reproducibility of MRI-Derived Resting Energy Expenditure Metabolism and integrative physiology Poster Mon Nov 16 2:30pm–3:30pm Application of Multi-Organ Imaging for Risk Stratification in Obesity Chronic disease and obesity complications |
Medifast Baltimore, MD | |
Company behind OPTAVIA, a coach-supported weight-loss program built on meal replacements, with a medically supported telehealth option. | Poster Sun Nov 15 2:30pm–3:30pm The GLP-1 Revolution: Real-World Success Using Branded and Compounded Medications via a Medically Supported Telehealth Program Obesity pharmacotherapy and drug developmentPolicy and public health Poster Mon Nov 16 2:30pm–3:30pm Longitudinal MIDUS Analysis of Healthy Lifestyle Habits and Weight and Waist Circumference Change Population health and epidemiologyNutrition, diet and food Poster Mon Nov 16 2:30pm–3:30pm Does "Metabolically Healthy" Obesity Last? Insights From 12-Year MIDUS Analysis Population health and epidemiologyNutrition, diet and food |
Israeli startup developing a food-grade bioactive peptide, for use in foods and supplements, that boosts the body's own GLP-1 response. | Poster Sat Nov 14 7:30pm–8:30pm GLP-1 Edge™ Improves Postprandial Glycemic Control in Adults With Prediabetes and Obesity Obesity pharmacotherapy and drug developmentMetabolism and integrative physiology Poster Sat Nov 14 7:30pm–8:30pm GLP-Edg: A Novel, Orally Administered GPR40 Agonist With a Local GI-Targeted Mechanism for Weight Management Obesity pharmacotherapy and drug developmentMetabolism and integrative physiology |
UK company developing a once-daily swallowable hydrogel capsule that expands in the stomach to curb appetite without hormonal action. | Poster Sun Nov 15 2:30pm–3:30pm Changes in BMI and Appetite After Novel Pill for Weight Loss in Women of Typical Perimenopausal Age Obesity pharmacotherapy and drug developmentInterventional and clinical studies Poster Sun Nov 15 2:30pm–3:30pm Perspectives on Weight Management Treatments and Clinical Trials in Underserved US and UK Groups Obesity pharmacotherapy and drug developmentInterventional and clinical studies |
Almond Board of California Modesto, CA | |
Grower-funded California almond marketing board that supports nutrition research and promotes almonds. | Talk Sun Nov 15 11:35am–12:05pm Every Bite Counts - The Role of Nutrient-Dense Foods in the GLP-1 Era Looks at how clinicians can help patients on GLP-1 drugs eat nutrient-dense foods such as almonds when they are eating less. Nutrition, diet and food |
AMRA Medical Linköping, Sweden | |
Company offering body composition analysis from MRI scans, used in obesity and metabolic trials. | Poster Sat Nov 14 7:30pm–8:30pm Variations in MRI Body Composition for Children Indicate Potential Differences in Risk Profile Neuroscience of appetite and eating |
JT JDS Therapeutics Purchase, NY | |
Developer of patented dietary supplement ingredients and women's health products. | Poster Sat Nov 14 7:30pm–8:30pm Uva Ursi and Pterostilbene Reduce Body Mass When Combined but not Alone in Diet-Induced Obesity Chronic disease and obesity complicationsObesity pharmacotherapy and drug development |
N NutriSci | |
Company studying the effects of botanicals on body weight and GLP-1 levels on a high-fat diet. | Poster Mon Nov 16 2:30pm–3:30pm The Effects of Various Botanicals on Body Weight and GLP-1 Levels in High-Fat Diet Fed Rodents Nutrition, diet and foodPopulation health and epidemiology |
Whole-body MRI screening clinics for early detection of disease. | Talk Mon Nov 16 4:00pm–4:15pm |
Digital health company using wearables and connected devices to capture real-world activity, sleep and lifestyle data for researchers and clinicians. | Booth Exhibiting at Booth 736 Sat, Nov 147pm–9:30pmSun, Nov 159:30am–4pmMon, Nov 169:30am–4pm |
Nutrition and wellness company listed on the exhibit floor plan, with no published profile. | Booth Exhibiting at Booth 125 Sat, Nov 147pm–9:30pmSun, Nov 159:30am–4pmMon, Nov 169:30am–4pm |
Maker of vitamin and mineral supplements formulated for people who have had bariatric surgery. | Booth Exhibiting at Booth 302 Sat, Nov 147pm–9:30pmSun, Nov 159:30am–4pmMon, Nov 169:30am–4pm |
Supplement brand for women losing weight with medical treatment. | Booth Exhibiting at Booth 836 Sat, Nov 147pm–9:30pmSun, Nov 159:30am–4pmMon, Nov 169:30am–4pm |
Boston Scientific Marlborough, MA | |
Medical device company making less invasive technologies to diagnose and treat a wide range of conditions. | Booth Exhibiting at Booth 433 Sat, Nov 147pm–9:30pmSun, Nov 159:30am–4pmMon, Nov 169:30am–4pm |
Maker of Breezing Med, an FDA-cleared indirect calorimeter that measures resting metabolic rate and respiratory quotient from breath gases. | Booth Exhibiting at Booth 822 Sat, Nov 147pm–9:30pmSun, Nov 159:30am–4pmMon, Nov 169:30am–4pm |
Over-the-counter ointment that protects and soothes skin irritated by moisture such as incontinence, sweat or wound drainage. | Booth Exhibiting at Booth 721 Sat, Nov 147pm–9:30pmSun, Nov 159:30am–4pmMon, Nov 169:30am–4pm |
Find buyers from device, diagnostics and nutrition companies
Tell us what you sell and we’ll find the people at these device, diagnostics and nutrition companies most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Browse ObesityWeek 2026 by
Organization type
Topic
- Obesity pharmacotherapy and drug development 251
- Clinical obesity care and professional practice 196
- Interventional and clinical studies 231
- Metabolism and integrative physiology 217
- Nutrition, diet and food 164
- Pediatric and adolescent obesity 117
- Population health and epidemiology 156
- Chronic disease and obesity complications 224
- Neuroscience of appetite and eating 97
- Bariatric surgery and devices 58
- Policy and public health 102
Exhibit hall
Everyone
Not affiliated with or endorsed by The Obesity Society (TOS), ObesityWeek® or the American Society for Metabolic and Bariatric Surgery (ASMBS). Submit a correction